Publication | Open Access
Depsipeptide Companeramides from a Panamanian Marine Cyanobacterium Associated with the Coibamide Producer
58
Citations
20
References
2015
Year
Peptide ScienceAntimicrobial ChemotherapyCyanobacteriaChemical BiologyDepsipeptide CompaneramidesPharmaceutical ChemistryMedicinal ChemistryMicrobial EcologyEnvironmental MicrobiologyNew Cyclic DepsipeptidesAntimicrobial Drug DiscoveryCoibamide ProducerBiochemistryBioassay-guided IsolationPlanar StructuresAntibacterial AgentAntimicrobial CompoundPharmacologyMarine BiotaBiomolecular EngineeringCoiba IslandBiologyNatural SciencesMicrobiologyMarine BiologyMedicineDrug DiscoveryDrug Analysis
Two new cyclic depsipeptides, companeramides A (1) and B (2), have been isolated from the phylogenetically characterized cyanobacterial collection that yielded the previously reported cancer cell toxin coibamide A (collected from Coiba Island, Panama). The planar structures of the companeramides, which contain 3-amino-2-methyl-7-octynoic acid (Amoya), hydroxy isovaleric acid (Hiva), and eight α-amino acid units, were established by NMR spectroscopy and mass spectrometry. The absolute configuration of each companeramide was assigned using a combination of Marfey's methodology and chiral-phase HPLC analysis of complete and partial hydrolysis products compared to commercial and synthesized standards. Companeramides A (1) and B (2) showed high nanomolar in vitro antiplasmodial activity but were not overtly cytotoxic to four human cancer cell lines at the doses tested.
| Year | Citations | |
|---|---|---|
Page 1
Page 1